<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26</volume><submitter>Bargeri S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Several systematic reviews (SRs) assessing the use of telemedicine for musculoskeletal conditions have been published in recent years. However, the landscape of evidence on multiple clinical outcomes remains unclear.&lt;h4>Objective&lt;/h4>We aimed to summarize the available evidence from SRs on telemedicine for musculoskeletal disorders.&lt;h4>Methods&lt;/h4>We conducted an umbrella review of SRs with and without meta-analysis by searching PubMed and EMBASE up to July 25, 2022, for SRs of randomized controlled trials assessing telemedicine. We collected any kind of patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), and objective measures, including direct and indirect costs. We assessed the methodological quality with the AMSTAR 2 tool (A Measu</pubmed_abstract><journal>Journal of medical Internet research</journal><pagination>e50090</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10873802</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review.</pubmed_title><pmcid>PMC10873802</pmcid><pubmed_authors>Castellini G</pubmed_authors><pubmed_authors>Banfi G</pubmed_authors><pubmed_authors>Pennestri F</pubmed_authors><pubmed_authors>Guida S</pubmed_authors><pubmed_authors>Gianola S</pubmed_authors><pubmed_authors>Bargeri S</pubmed_authors><pubmed_authors>Vitale JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review.</name><description>&lt;h4>Background&lt;/h4>Several systematic reviews (SRs) assessing the use of telemedicine for musculoskeletal conditions have been published in recent years. However, the landscape of evidence on multiple clinical outcomes remains unclear.&lt;h4>Objective&lt;/h4>We aimed to summarize the available evidence from SRs on telemedicine for musculoskeletal disorders.&lt;h4>Methods&lt;/h4>We conducted an umbrella review of SRs with and without meta-analysis by searching PubMed and EMBASE up to July 25, 2022, for SRs of randomized controlled trials assessing telemedicine. We collected any kind of patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), and objective measures, including direct and indirect costs. We assessed the methodological quality with the AMSTAR 2 tool (A Measu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-09T07:13:21.467Z</modification><creation>2025-04-20T04:02:50.732Z</creation></dates><accession>S-EPMC10873802</accession><cross_references><pubmed>38306156</pubmed><doi>10.2196/50090</doi></cross_references></HashMap>